What Makes Gallant Different?
Regenerative medicine that goes deeper
Mesenchymal stromal cells have intrinsic properties that allow them to restore health at the source by:
- rebalancing the immune system
- reducing inflammation
- promoting tissue repair
Our Therapies in Development
Every therapy in our pipeline follows the FDA’s structured review and approval process—ensuring quality, consistency, and a path to expand the spectrum of care for pets.
| Pre-clinical |
proof of concept |
Controlled field study | Pivotal study | Commercially available | |
|---|---|---|---|---|---|
|
Feline Chronic Gingivostomatitis
|
|
||||
|
Feline Osteoarthritis
|
|
||||
|
Canine Osteoarthritis
|
|
||||
|
Feline Chronic Kidney Disease
|
|
||||
|
Canine Atopic Dermatitis
|
|
||||
Explore our Clinical Trials
Be a pet health hero
We’re working with veterinarians and families across the U.S. to bring MSC therapies to pets.
Learn more about our clinical trials.
A Simpler Way
Designed to incorporate into practice workflow
Gallant’s investigational MSC therapies are backed by clinical trial data, delivered ready-to-use, and administered through an intravenous injection.
Making Headlines in Animal Health
Gallant is being recognized for advancing regenerative medicine with rigor, transparency, and a practical focus.
The Latest from Gallant
Work With Us
Where science meets mission
Gallant is redefining what’s possible in pet health—and it takes passionate people from every discipline to make it happen. If you’re driven by purpose, energized by innovation, and ready to help bring regenerative medicine to more pets, let’s talk.
